Safety of stimulant medications for attention deficit hyperactivity disorder in paediatric congenital heart disease
- 15 February 2023
- journal article
- editorial
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 59 (3) , 580-588
Abstract
Aim: To review current literature regarding the safety of stimulant medications for treatment of attention deficit hyperactivity disorder in paediatric congenital heart disease (CHD) patients.Methods: Embase, MEDLINE complete, CINAHL complete and Psychology and Behavioural Sciences Collection were searched for relevant articles from January 1980 to July 2022.Results: One hundred and three articles were identified during the initial search after removal of duplicates. Thirty‐five articles were selected for review and 11 were included as relevant to the clinical question.Conclusions: Stimulant medications are safe in patients with underlying CHD. In mild congenital cardiac conditions (ventricular septal defect, atrial septal defect and isolated semilunar valve disease), paediatricians can safely initiate stimulant therapy. With complex CHD cases, cardiology opinion is recommended prior to starting stimulants.Keywords
This publication has 19 references indexed in Scilit:
- How to Predict the Impact of Methylphenidate on Cardiovascular Risk in Children with Attention Deficit Disorder: Methylphenidate Improves Autonomic Dysfunction in Children with ADHDISRN Pharmacology, 2012
- ADHD Drugs and Serious Cardiovascular Events in Children and Young AdultsNew England Journal of Medicine, 2011
- Cardiovascular Events and Death in Children Exposed and Unexposed to ADHD AgentsPediatrics, 2011
- Sudden Death and Use of Stimulant Medications in YouthsAmerican Journal of Psychiatry, 2009
- Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity DisorderCirculation, 2008
- The Role of the Autonomic Nervous System in Sudden Cardiac DeathProgress in Cardiovascular Diseases, 2008
- Current insights regarding neurological and developmental abnormalities in children and young adults with complex congenital cardiac diseaseCardiology in the Young, 2006
- Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents With Velocardiofacial SyndromeThe Journal of Clinical Psychiatry, 2003
- Genotype-Phenotype Correlation in the Long-QT SyndromeCirculation, 2001
- Cellular Basis for the ECG Features of the LQT1 Form of the Long-QT SyndromeCirculation, 1998